NICE Gives Soft ‘No’ to Janssen’s Leukemia Treatment, Rejects Roche’s Perjeta

The UK’s National Institute for Health and Care Excellence refused to recommend Janssen’s chronic lymphocytic leukemia treatment Imbruvica for reimbursement in June, but left the door open to further discussion.…

Continue ReadingNICE Gives Soft ‘No’ to Janssen’s Leukemia Treatment, Rejects Roche’s Perjeta

France to Tighten Clinical Trial Regulations Following Fatal Trial, EMA to Conduct Review

France is tightening restrictions on early-phase clinical trials in the wake of one study that left one patient brain-dead and hospitalized five others. Source: International Pharmaceutical Regulatory Monitor

Continue ReadingFrance to Tighten Clinical Trial Regulations Following Fatal Trial, EMA to Conduct Review